Biotechnology
/
Eastern Norway

Biomolex AS

Africa
Asia
Denmark
Europe
North America
Oceania
South America
South Asia
Sweden
West Asia
  • Finance
    Total revenues: 6.099
    Operating profit: 2.477
    Operating profit before tax: 2.48
    Total assets: 10.402
    Total equity: 4.6
    Currency: NOK (all numbers in thousands)
  • Management
    Board Chairman:
    Eirik Næss-Ulseth

    Board Members:
    Grete Vigen Rode
    Jonas Einarsson

    General Manager:
    Håvard Hildeng Hauge

    Subsidiary companies:
    Largest shareholders:
    N/A
    Biomedical equipment, Biotechnology, Medicinal Service, Research and experimental development services,